Bulsufan decreases the incidence of mixed chimaerism in HLA-matched donor transplantation for severe aplastic anaemia

Lan-Ping Xu; Zheng-Li Xu; Yuan-Yuan Zhang; Yi-Fei Cheng; Xiao-Dong Mo; Ting-Ting Han; Feng-Rong Wang; Chen-Hua Yan; Yu-Qian Sun; Yu-Hong Chen; Fei-Fei Tang; Wei Han; Yu Wang; Xiao-Hui Zhang; Kai-Yan Liu; Xiao-Jun Huang

doi:10.1038/s41409-022-01682-x

Bulsufan decreases the incidence of mixed chimaerism in HLA-matched donor transplantation for severe aplastic anaemia

Bone Marrow Transplant. 2022 Jul;57(7):1204-1206. doi: 10.1038/s41409-022-01682-x. Epub 2022 May 4.

Authors

Lan-Ping Xu^#^{1

2}, Zheng-Li Xu^#^{1

2}, Yuan-Yuan Zhang^{1

2}, Yi-Fei Cheng^{1

2}, Xiao-Dong Mo^{1

2}, Ting-Ting Han^{1

2}, Feng-Rong Wang^{1

2}, Chen-Hua Yan^{1

2}, Yu-Qian Sun^{1

2}, Yu-Hong Chen^{1

2}, Fei-Fei Tang^{1

2}, Wei Han^{1

2}, Yu Wang^{1

2}, Xiao-Hui Zhang^{1

2}, Kai-Yan Liu^{1

2}, Xiao-Jun Huang^{3

4

5

6}

Affiliations

¹ Peking University People's Hospital, Peking University Institute of Hematology, Beijing, China.
² National Clinical Research Center for Hematologic Disease, Beijing, China.
³ Peking University People's Hospital, Peking University Institute of Hematology, Beijing, China. huangxiaojun@bjmu.edu.cn.
⁴ National Clinical Research Center for Hematologic Disease, Beijing, China. huangxiaojun@bjmu.edu.cn.
⁵ Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China. huangxiaojun@bjmu.edu.cn.
⁶ Peking-Tsinghua Center for Life Sciences, Beijing, China. huangxiaojun@bjmu.edu.cn.

^# Contributed equally.

PMID: 35508709
DOI: 10.1038/s41409-022-01682-x

No abstract available

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

Anemia, Aplastic* / complications
Anemia, Aplastic* / therapy
Bone Marrow Transplantation / adverse effects
Graft vs Host Disease* / etiology
Humans
Incidence
Tissue Donors